Immunogenic peptide mimotopes from an epitope of Escherichia coli O157 LPS.
Escherichia coli O157:H7 is a subtype of Shiga toxin-producing E. coli that is associated with haemorrhagic colitis and haemolytic uremic syndrome (HUS). Studies of populations in endemic areas have reported that the presence of specific antibodies against the O157 lipopolysaccharide (LPS) is associated with a lower incidence of diarrhoea and HUS. Phage display and IgG anti-O157 LPS antibodies were used in the present study to select peptide mimotopes of O157 LPS expressed in protein III of the M13 phage. Synthetic peptides (SP) were designed using the derived amino acid sequences obtained from DNA nucleotides of 63 selected phagotopes. The LxP/YP/SxL motif was identified in five of the phagotope amino acid sequences. Antibody responses against the phagotopes and their corresponding SPs were evaluated. SP12, one of the designed SP, induced the production of antibodies against the homologous peptide (1:800) and O157 LPS (1:200). The specificity of anti-SP12 antiserum was confirmed by analyzing its response to SP3, an SP with a different amino acid sequence than that of SP12, as well as against an E. coli LPS different from O157. Competitive studies with SP12 and O157 LPS showed a significant decrease in anti-SP12 and anti-LPS O157 antiserum responses against SP12 and O157 LPS, respectively. Eighteen (82%) of the 22 human serum samples with positive reactivity against E coli O157 LPS reacted with SP12 SP (cut-off >0.4). These results support the idea that SP12 is an immunogenic mimotope of O157 LPS.
Department of Public Health, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, Mexico.
Armando
A
Navarro
Laboratorio de Patogenicidad Bacteriana, Unidad de Hemato-Oncología e Investigación, Hospital Infantil de México Federico Gómez, Dr Márquez 162, Col. Doctores, Delegación Cuauhtémoc, Mexico C.P. 06720, Mexico División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico, Mexico.
Ulises
U
Hernández-Chiñas
Department of Public Health, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, Mexico.
Delia
D
Licona-Moreno
Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, Mexico.
Edgar
E
Zenteno
Global Evaluative Sciences USA, Inc., Seattle, WA, USA.
Alejandro
A
Cravioto
Laboratorio de Patogenicidad Bacteriana, Unidad de Hemato-Oncología e Investigación, Hospital Infantil de México Federico Gómez, Dr Márquez 162, Col. Doctores, Delegación Cuauhtémoc, Mexico C.P. 06720, Mexico División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico, Mexico.
Carlos A
CA
Eslava-Campos
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000939:Epitopes / Q000737:chemistry* / Q000276:immunology*; D019453:Escherichia coli O157 / Q000276:immunology* / Q000378:metabolism; D006463:Hemolytic-Uremic Syndrome / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology; D010455:Peptides / Q000737:chemistry* / Q000276:immunology*; D011817:Rabbits; D044967:Serum / Q000276:immunology
D000906:Antibodies; D000939:Epitopes; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D010455:Peptides
E. coli O157:H7; O157 LPS; immunogenic peptides; mimotopes; phagotope; synthetic peptides